News

On 29 June this year the first Early Phase Trial Oncology in Poland was opened in the Maria Skłodowska-Curie Institute of Oncology in Warsaw. During the scientific session, Aleksandra Stańczak, MD – leader of the Oncology Research group – presented the following project: Celonko – an innovative anti-FGFR therapy for patients with urinary bladder, lung andRead more »

Celon Pharma S.A. was awarded in the category of companies with revenues ranging from PLN 50 to 250 million and was placed 10th in the entire ranking in the Mazowieckie voivodship. Forbes Diamonds are awarded to the most dynamically developing companies in Poland. The award was accepted on behalf of the company by Iwona Giedronowicz,Read more »

On 19 June this year, Maciej Wieczorek was invited by the Industrial Development Agency to participate in a meeting entitled: Quo vadis medicine. The pharmaceutical market and perspectives for its development. During the discussion panel attended by representatives of pharmaceutical companies, trade unions and VC funds, effective instruments for financing innovation in pharmacy and theRead more »

A meeting of Celon Pharma S.A. with its institutional and individual investors took place on 15 May this year. We encourage you to see the video coverage of that meeting:

We encourage you to read Celon Pharma S.A.’s Yearly Report for 2016.